Romulus Brazzell

Romulus Brazzell

Chief Tech/Sci/R&D Officer chez KALA BIO, INC.

Fortune : 37 594 $ au 31/03/2024

71 ans
Health Technology
Consumer Services
Finance

Profil

Romulus Kim Brazzell is currently the Chief Medical Officer and Head of Research & Development at KALA BIO, Inc. He previously held positions as the Associate Director of Research & Development at Alcon Laboratories, Inc., the Executive VP of Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc., the Senior Vice President of US Research & Development at Novartis Ophthalmics, Inc., the Chief Medical Officer at Mimetogen Pharmaceuticals, Inc., the Vice President of Research & Development at Ciba Vision Ophthalmics Co., and as a Principal at Acuity Advisors LLC.
Dr. Brazzell obtained his undergraduate and doctorate degrees from the University of Kentucky.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
04/01/2024 4 717 ( 0,18% ) 37 594 $ 31/03/2024

Postes actifs de Romulus Brazzell

SociétésPosteDébut
KALA BIO, INC. Chief Tech/Sci/R&D Officer 01/02/2013
Tous les postes actifs de Romulus Brazzell

Anciens postes connus de Romulus Brazzell

SociétésPosteFin
Corporate Officer/Principal 01/07/2018
Chief Tech/Sci/R&D Officer 01/12/2015
Chief Tech/Sci/R&D Officer 01/01/2011
Chief Tech/Sci/R&D Officer 01/01/2004
Ciba Vision Ophthalmics Co. Chief Tech/Sci/R&D Officer 01/01/2000
Voir l'expérience en détail de Romulus Brazzell

Formation de Romulus Brazzell

University of Kentucky Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Romulus Brazzell

Relations

57

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
KALA BIO, INC.

Health Technology

Entreprise privées6

Health Technology

Health Technology

Health Technology

Health Technology

Ciba Vision Ophthalmics Co.

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Romulus Brazzell